Day: June 26, 2024

Newly Launched ProFound Cloud Delivers Radiologists Cost-Effective, Secure, and Scalable Access to iCAD’s Breast Health Suite of AI Solutions NASHUA, N.H., June 26, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, today announced it will highlight new research demonstrating the efficacy of its ProFound AI Risk algorithm in breast cancer risk assessment compared to traditional models at the upcoming Society for Imaging Informatics in Medicine (SIIM) Annual Meeting. The company will also highlight its recently launched ProFound Cloud, an advanced software-as-a-service (SaaS) platform that offers medical providers a cost-effective, secure, and scalable solution for accessing and deploying the latest ProFound Breast Health Suite of AI solutions. Mark Traill,...

VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, today announced that its scientific collaborators, Drs. Vern Lewis and Argel Aguilar-Valles from Carleton University’s Department of Neuroscience (Ottawa, Canada), will present data from a study investigating the mechanisms of BETR-001 (2-bromo-LSD) at the upcoming FENS conference on June 25-29 in Vienna, Austria. BETR-001 is a non-hallucinogenic derivative of LSD, proprietary to BetterLife (patent pending). The study is titled “Cortical transcriptomic effects of the non-hallucinogenic 2-Bromo-LSD”. Dr. Lewis will present preclinical gene sequencing...

That being said, a majority of executives surveyed hold a positive view of AI, with 64% expressing optimism about the new technologyLayoffs Hit 50% of Finance Companies SurveyedTo help executives understand, react, and adapt to the ongoing challenges within the finance industry, Fiverr has released a new report, Strategic Insights: Leveraging Freelance Talent in Finance.NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) — To help executives understand, react, and adapt to the ongoing challenges within the finance industry, Fiverr (NYSE: FVRR) has released a new report, Strategic Insights: Leveraging Freelance Talent in Finance. The report dives into pain points in the sector, including in which quarter leaders feel the most stressed (the second quarter) and offers insight into how executives in the sector are adapting to and overcoming...

Boston event to focus on Immunology & Inflammation (I&I) and Metabolic Diseases BRIDGEWATER, N.J., June 26, 2024 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced members of VYNE’s management will participate in one-on-one meetings at the Leerink Partners Therapeutics Forum on Immunology and Inflammation (I&I) and Metabolic Diseases on Tuesday, July 9, 2024. About VYNE Therapeutics Inc.VYNE’s mission is to improve the lives of patients by developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. The Company’s unique and proprietary bromodomain &...

NAPLES, Fla., June 26, 2024 (GLOBE NEWSWIRE) — HealthLynked Corp. (OTCQB: HLYK), a pioneering provider of healthcare technology solutions, is pleased to announce the promotion of Bill Crupi to the position of Chief Operating Officer (COO), effective immediately. This strategic appointment underscores HealthLynked’s commitment to operational excellence and its vision to enhance healthcare connectivity. Bill Crupi joined HealthLynked in 2023 and has since been instrumental in optimizing operational efficiencies and supporting the company’s growth trajectory. With over two decades of experience in the healthcare sector, Bill has demonstrated exceptional leadership in operations management and has been a driving force in advancing HealthLynked’s mission to connect patients and healthcare providers through innovative...

6th International Navy to Select LRAD 950NXTs for Long-Range Communication and Scalable Escalation of Force SAN DIEGO, June 26, 2024 (GLOBE NEWSWIRE) —  Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications, today announced an LRAD 950NXT systems order from Damen Schelde Naval Shipbuilding B.V. (Damen) for the German Navy’s new F-126 frigates, the largest shipbuilding project in the history of the German Navy. Damen will outfit four frigates with multiple LRAD 950NXT systems, with an option to outfit two additional frigates. The first shipment is scheduled this September with further shipments in fiscal years 2025 and 2026 “Since its launch two years ago, the 950NXT has quickly become the world’s leading remotely operated, maritime acoustic hailing device (AHD) with six international navies and several superyacht...

MIAMI, June 26, 2024 (GLOBE NEWSWIRE) — AYR Cannabis Dispensary, a cannabis retail chain owned by AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), today announced the opening of AYR Cannabis Dispensary Hometown, the Company’s third retail location in Illinois and 92nd nationwide. Located in a suburb of Chicago at 4140 SW Hwy, Hometown, IL 60456, AYR Cannabis Dispensary Hometown began serving adult-use consumers on June 25. The dispensary features a welcoming environment for customers with a retail floor of approximately 4,200 square feet. “We’re proud to continue our growth in Illinois with the opening of AYR Cannabis Dispensary Hometown, our third location in the state and 92nd nationwide,” said David Goubert, President...

CHANDLER, Ariz., June 26, 2024 (GLOBE NEWSWIRE) — One of Microchip’s Guiding Values is “Professional Ethics and Social Responsibility Are Practiced,” which means that the company manages its business and treats its customers, employees, shareholders, investors, suppliers, channel partners, community and government in a manner that exemplifies honesty, ethics and integrity. To demonstrate its commitment to this value and to provide transparency to its employees, customers and all other stakeholders, Microchip Technology (Nasdaq: MCHP) has released its 2023 Sustainability Report which details its environmental and social impact programs. Microchip’s Environmental, Social and Governance (ESG) projects are aligned with its business objectives and are implemented to catalyze positive change throughout its value chain via strategic initiatives,...

LAS VEGAS, June 26, 2024 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company is expecting to receive an expanded certified geological technical report during the 3rd quarter on its 100% owned registered concession at the Bonanza Gold Mine Project located in Acaponeta, Nayarit, Mexico. The Company will be broadening its ongoing exploration and development activities at Bonanza directed by the new guidances and recommendations contained in the upcoming second technical report. The outstanding indications revealed during the compilation process of the new report signify the potential for a substantial increase in development scope and production planning for the Bonanza property. The preliminary mineral resource estimates of gold and silver values contained in the initial...

Selected for oral presentation Conference will be held in Milan on September 21-23MADRID and CAMBRIDGE, Mass., June 26, 2024 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today announced that it will present final data from its Phase IIb PORTICO trial, which investigated the efficacy of vafidemstat in the treatment of Borderline Personality Disorder (BPD), as an oral presentation at the 37th European College of Neuropsychopharmacology (ECNP) annual conference, to be held on September 21-23, 2024 in Milan, Italy. Dr. Michael Ropacki, Oryzon’s Chief Medical Officer, Head of CNS Clinical Development, will be presenting the results at the ECNP New Medication Symposium on September...